WA-SPIE
10.1.2024 20:46:32 CET | Business Wire | Press release
The Awards Committee of SPIE, the international society for optics and photonics, today announced the recipients of its prestigious annual awards. Honoring transformative advancements in a variety of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110537408/en/
Akhlesh Lakhtakia, the 2024 recipient of the SPIE Gold Medal. (Photo: Business Wire)
SPIE Gold Medal: Akhlesh Lakhtakia
For pioneering research on electromagnetic fields in complex materials including isotropic chiral, bianisotropic, and composite materials, metamaterials, and nanomaterials.
SPIE President's Award: Katie Schwertz
For outstanding service to SPIE and the optics community, through work that advances optical systems design, engages students, and shares the excitement of optics with the public.
SPIE Directors' Award: Halina Rubinsztein-Dunlop
For pioneering research in optics and photonics, and for distinguished service to SPIE as a leading light in promoting educational programs and supporting women in science.
SPIE Mozi Award: Andrea Alù
For seminal contributions to the field of optical metamaterials as well as their applications for wavefront manipulation and enhancement of nonreciprocal and nonlinear phenomena.
SPIE Mozi Award: Teri W. Odom
For significant contributions to the field of nanophotonics and to the development of moiré photonics.
SPIE Britton Chance Award in Biomedical Optics: Gerard L. Coté
For transformative advances in both fundamental and translational optical research toward the diagnosis and monitoring of chronic and infectious diseases.
SPIE Biophotonics Technology Innovator Award: Ji-Xin Cheng
For the invention and commercialization of mid-infrared photothermal microscopy that allows highly sensitive dye-free bond-selective imaging of living cells and organisms.
SPIE Rudolf and Hilda Kingslake Award in Optical Design: David Shafer
For outstanding contributions to the field of optical design including DUV and EUV photolithographic scanner designs that define the current technological limit of the semiconductor industry.
SPIE Harrison H. Barrett Award in Medical Imaging: Kyle J. Myers
For fundamental contributions to the field of image science, with an emphasis on the role of science in regulatory evaluations of imaging methods.
SPIE Harold E. Edgerton Award in High-Speed Optics: Clara Saraceno
For groundbreaking contributions to the development of ultrafast high-power lasers and laser-driven THz sources.
SPIE Dennis Gabor Award in Diffractive Optics: Jürgen Czarske
For significant contributions to the development of digital holography, and related techniques for biomedicine, fiber communication, imaging, information processing, and laser metrology.
SPIE A.E. Conrady Award in Optical Engineering: Thomas U. Kampe
For industry-recognized leadership in optical engineering, design, and development – including critical Earth-monitoring instruments – as well as for mentoring the next generation of optical engineers.
SPIE G. G. Stokes Award in Optical Polarization: Curtis R. Menyuk
For pioneering studies of linear and nonlinear polarization effects in guided-wave photonics which have impacted basic science, telecommunications systems, lasers, and many other photonics-based technologies.
SPIE Chandra S. Vikram Award in Optical Metrology: Anand Asundi
For numerous contributions to coherent optical metrology and sensing, with special attention to digital technologies.
SPIE Frits Zernike Award for Microlithography: Richard Sandstrom
For leadership in the development of lithographic-grade lasers and EUV light sources.
SPIE Diversity Outreach Award: Preeti Jagadev
For excellence in promoting and advocating diversity, equity, and inclusion in STEM.
SPIE Maria Goeppert Mayer Award in Photonics: Iam-Choon Khoo
For foundational contributions to linear and nonlinear optical properties of liquid crystals and their applications in wide-ranging, wave-mixing, and self-action effects.
SPIE Maiman Laser Award: Anne L’Huillier
For the discovery of high harmonic generation in gases, and contributions to developments in attoscience.
SPIE María J. Yzuel Educator Award: Mary G. Turner
For a lifetime of dedication to the teaching of optical design, and for services to the optics community.
SPIE Aden and Marjorie Meinel Technology Achievement Award: M. Saif Islam
For highly impactful innovations in ultra-fast and highly efficient photodetectors enabled by photon-trapping structures.
The complete listing of the SPIE Society Awards and recipients is available here.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $24 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110537408/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom